Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
ARMP · against 111 other Healthcare companies of similar size
Ranked #78 of 112 · scores higher than 5% of peers
Bars: peers in each 10-point band of the valuation score35 peers with a valuation score of 0–9, including ARMP · Click a bar to see the companies
Mainly because of its earnings yield, free cash flow yield and EBITDA yield, which are weaker than most Healthcare peers.
| Metric | ARMP | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 96 reported | -171.2% | -12.4% | 6% | 30% | |
| EBITDA yieldHigher is better · 119 reported | -8.3% | -1.8% | 39% | 50% | |
| Free cash flow yieldHigher is better · 85 reported | -21.3% | -15.7% | 44% | 20% | |
| Book yieldHigher is better · 100 reported | -201.4% | 70.9% | 0% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 1.1B HKD (≈$146M) | 99 | 72 | |
| 1 | 834M HKD (≈$107M) | 99 | 57 | |
| 1 | 1.4B HKD (≈$181M) | 99 | 61 | |
| 1 | 29.0B JPY (≈$197M) | 99 | 56 | |
| 1 | 592M ILS (≈$160M) | 99 | 84 | |
| 78 | 3.4B TWD (≈$106M) | 8 | 36 | |
| 78 | 7.2B TWD (≈$224M) | 8 | 41 | |
| 78 | 198M USD | 8 | 10 | |
| 78 | 201M USD | 8 | 24 | |
| 78 | 115M USD | 8 | 8 | |
| 78 | 82M USD | 8 | 27 | |
| 78 | 222M USD | 8 | 31 | |
| 78 | 118M USD | 8 | 13 | |
| 78 | 67M USD | 8 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score